LiSheng Chu - PharmaEngine Independent Director

4162 Stock  TWD 96.80  0.30  0.31%   

Director

Mr. Frank LiSheng Chu was serving as Independent Director in PharmaEngine, Inc. since June 20, 2013. He holds a Master degree in Commerce from National Taiwan University. He is also Independent Director in Yue Yuen Industrial Limited and WELLPOOL CO., Ltd. since 2013.
Tenure 11 years
Phone886 2 2515 8228
Webhttps://www.pharmaengine.com

PharmaEngine Management Efficiency

The company has return on total asset (ROA) of 0.0589 % which means that it generated a profit of $0.0589 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0985 %, meaning that it generated $0.0985 on every $100 dollars invested by stockholders. PharmaEngine's management efficiency ratios could be used to measure how well PharmaEngine manages its routine affairs as well as how well it operates its assets and liabilities.

Similar Executives

Showing other executives

DIRECTOR Age

Yizong ZhangSan Fu Chemical
N/A
Boxi LiaoGoldsun Building Materials
N/A
Honglong HuangPhoenix Silicon International
N/A
Guofeng LinPhoenix Silicon International
N/A
Yingwen ZhanGoldsun Building Materials
N/A
Huaikun YangEternal Materials Co
N/A
Shizong ZhangGoldsun Building Materials
N/A
Chunmei LinGoldsun Building Materials
N/A
Shundi HongChinese Maritime Transport
N/A
Guoyuan LiangSan Fu Chemical
N/A
Jianqiang WuGoldsun Building Materials
N/A
Shirong ZhanGrand Plastic Technology
N/A
Taihong LinGoldsun Building Materials
N/A
Youmei HeGrand Plastic Technology
N/A
Hongrong GaoQualipoly Chemical Corp
N/A
Yaoming WangSan Fu Chemical
N/A
Tianling ZhuChinese Maritime Transport
N/A
Wenliang ZengQualipoly Chemical Corp
N/A
Mingji ZhangGoldsun Building Materials
N/A
Qide HongGoldsun Building Materials
N/A
Chongyi JiangGrand Plastic Technology
N/A
PharmaEngine (4162) is traded on Taiwan OTC Exchange in Taiwan and employs 41 people.

Management Performance

PharmaEngine Leadership Team

Elected by the shareholders, the PharmaEngine's board of directors comprises two types of representatives: PharmaEngine inside directors who are chosen from within the company, and outside directors, selected externally and held independent of PharmaEngine. The board's role is to monitor PharmaEngine's management team and ensure that shareholders' interests are well served. PharmaEngine's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, PharmaEngine's outside directors are responsible for providing unbiased perspectives on the board's policies.
Xiuji Zhang, Director
Lin C, Director
PoWu Gean, Director
Changjing Ye, CEO, General Manager, Director
HongRen Wang, Pres CEO
Yusheng Zhao, Director
LiSheng Chu, Independent Director
Fuxiu Yin, Independent Director
Guocai Pan, Director
Yuqing Su, Independent Director
ChiHsing Chang, VP Devel
Kunhong Lai, Independent Director
Chuan Lin, Director
YuFang Hu, General Manager
Bowu Jian, Director
Qiying Huang, Director
Jinrong Lin, Director
Jeffrey Suen, Chairman of the Board
Peter Wu, Director Sales
Junhui He, Chairman of the Board
Quan Lin, Director
Zhili Wang, Independent Director
C Chang, Deputy General Manager-Finance & Administration
Kangji Zhou, Independent Director
Hubert Chan, Deputy General Manager-Clinical & Regulatory Affairs
KangChi Chou, Independent Director
Melody Lin, Director HR
Lizhen Lin, Director
Li Lin, Director
Qixing Zhang, Senior Head-Finance and Administration Management
WenHwa Chang, Director
Ruiwen Wu, Director
Yihui Lin, Director
Jose Hsieh, Sr Accounting
Zhaosheng Wu, Deputy Head of Development Department
FuShiow Yin, Independent Director
Huai Wang, Independent Director
Grace Yeh, CEO, General Manager, Director
Qixiang Chen, Director
MingThau Sheu, Director
Xinyi Lin, Director

PharmaEngine Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is PharmaEngine a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards PharmaEngine in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, PharmaEngine's short interest history, or implied volatility extrapolated from PharmaEngine options trading.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Thematic Ideas
Explore Investing Ideas  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in PharmaEngine. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Complementary Tools for PharmaEngine Stock analysis

When running PharmaEngine's price analysis, check to measure PharmaEngine's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PharmaEngine is operating at the current time. Most of PharmaEngine's value examination focuses on studying past and present price action to predict the probability of PharmaEngine's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PharmaEngine's price. Additionally, you may evaluate how the addition of PharmaEngine to your portfolios can decrease your overall portfolio volatility.
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Please note, there is a significant difference between PharmaEngine's value and its price as these two are different measures arrived at by different means. Investors typically determine if PharmaEngine is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, PharmaEngine's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.